IMMUNOTHERAPY FOR CANCER

An antibody-drug conjugate (ADC) comprising an anti-human SEMA4A humanised or human antibody, a linker and a cytotoxin. L'invention concerne un conjugué anticorps-médicament (ADC) comprenant un anticorps humanisé ou humain anti-SEMA4A humain, un lieur et une cytotoxine.

Saved in:
Bibliographic Details
Main Authors GROVES, MARIA, ADDYMAN, ALEXANDRA, JENKINSON, LESLEY, CHAN, DENICE TSZ YAU, HAYNES, STUART, CHAPMAN, MICHAEL, LAPOINTE, JEAN-MARTIN, MARTIN, KIRSTY-JANE, VAUGHAN, TRISTAN, AUSTIN, MARK, BARNARD, MICHELLE, SLATER, LOUISE, ANDERSON, GEORGINA, DIAMANDAKIS, AGATA, HAWTHORNE, WILLIAM
Format Patent
LanguageEnglish
French
Published 15.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An antibody-drug conjugate (ADC) comprising an anti-human SEMA4A humanised or human antibody, a linker and a cytotoxin. L'invention concerne un conjugué anticorps-médicament (ADC) comprenant un anticorps humanisé ou humain anti-SEMA4A humain, un lieur et une cytotoxine.
AbstractList An antibody-drug conjugate (ADC) comprising an anti-human SEMA4A humanised or human antibody, a linker and a cytotoxin. L'invention concerne un conjugué anticorps-médicament (ADC) comprenant un anticorps humanisé ou humain anti-SEMA4A humain, un lieur et une cytotoxine.
Author ADDYMAN, ALEXANDRA
SLATER, LOUISE
LAPOINTE, JEAN-MARTIN
CHAN, DENICE TSZ YAU
HAYNES, STUART
JENKINSON, LESLEY
VAUGHAN, TRISTAN
ANDERSON, GEORGINA
HAWTHORNE, WILLIAM
BARNARD, MICHELLE
DIAMANDAKIS, AGATA
GROVES, MARIA
CHAPMAN, MICHAEL
MARTIN, KIRSTY-JANE
AUSTIN, MARK
Author_xml – fullname: GROVES, MARIA
– fullname: ADDYMAN, ALEXANDRA
– fullname: JENKINSON, LESLEY
– fullname: CHAN, DENICE TSZ YAU
– fullname: HAYNES, STUART
– fullname: CHAPMAN, MICHAEL
– fullname: LAPOINTE, JEAN-MARTIN
– fullname: MARTIN, KIRSTY-JANE
– fullname: VAUGHAN, TRISTAN
– fullname: AUSTIN, MARK
– fullname: BARNARD, MICHELLE
– fullname: SLATER, LOUISE
– fullname: ANDERSON, GEORGINA
– fullname: DIAMANDAKIS, AGATA
– fullname: HAWTHORNE, WILLIAM
BookMark eNrjYmDJy89L5WSQ8PT1DfXzD_FwDXIMiFRw8w9ScHb0c3YN4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6OxkYmBqaWFo6GxkQoAQCH1CEG
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate IMMUNOTHERAPIE POUR LE CANCER
ExternalDocumentID CA3240598A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA3240598A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:46:15 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA3240598A13
Notes Application Number: CA20223240598
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230615&DB=EPODOC&CC=CA&NR=3240598A1
ParticipantIDs epo_espacenet_CA3240598A1
PublicationCentury 2000
PublicationDate 20230615
PublicationDateYYYYMMDD 2023-06-15
PublicationDate_xml – month: 06
  year: 2023
  text: 20230615
  day: 15
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies CANCER RESEARCH TECHNOLOGY LIMITED
MEDIMMMUNE LIMITED
RelatedCompanies_xml – name: CANCER RESEARCH TECHNOLOGY LIMITED
– name: MEDIMMMUNE LIMITED
Score 3.4708104
Snippet An antibody-drug conjugate (ADC) comprising an anti-human SEMA4A humanised or human antibody, a linker and a cytotoxin. L'invention concerne un conjugué...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title IMMUNOTHERAPY FOR CANCER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230615&DB=EPODOC&locale=&CC=CA&NR=3240598A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQGdwZaWnKhrlmpqoGuSYpCma5FoaaqblgpszRqbpiSZpYA2OPv6mXmEmnhFmEYwMWTC9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGNSeNjRVc3GydQ3wd_F3VnN2tnV2VPMLsgWdO2dqaeEI7CixglrRoGP2XcOcQJtSCpBrFDdBBrYAoGF5JUIMTKl5wgyczrCL14QZOHyh891AJjTrFYswSHj6-ob6-Yd4uAY5BkQqADtvCs6gi2WCRBkU3FxDnD10gVbEw70T7-wId4yxGAMLsJefKsGgkJYI7CwaJaYYpplYmgCTbqKZpWmiiSGwgZYCzIYpSZIMkjiNkcIjJ83ABQoX0OomQ1MZBpaSotJUWWA9WpIkBw4BAACHc4E
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwED5VBVE2KKCWZwaULaKhcWiGCKVOohSah6IUlSly6ljq0lY0iL_POUoLC2yWLflx8vnus-8-A9xzycEmFkwzSzLQDD4Q2ohZRBMlerNDwguTywTnMDKDmfEyJ_MWLHe5MDVP6FdNjogatUB9r-rzevNzieXWsZXbh2KJVetnP7NdtUHH0p_WieqObS-J3ZiqlNrUUaPUlrxzxBo5CJQOniQ5r_Sc3sYyKWXz26L4J3CYYGer6hRa5aoLHbr7eK0LR2Hz3o3FRvW2Z9CbhOEsirPAS53kXUHwplD5sUx6DorvZTTQcIh8v5ycOvvJDC-gjSi_7IEiGILFR8Z1YVgGbl1mWoQZOjpoHNWQF33o_9nN5T9td9AJsnCaTyfR6xUcSxnJSCedXEO7-vgsb9CmVsVtLY1vjtV2bg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=IMMUNOTHERAPY+FOR+CANCER&rft.inventor=GROVES%2C+MARIA&rft.inventor=ADDYMAN%2C+ALEXANDRA&rft.inventor=JENKINSON%2C+LESLEY&rft.inventor=CHAN%2C+DENICE+TSZ+YAU&rft.inventor=HAYNES%2C+STUART&rft.inventor=CHAPMAN%2C+MICHAEL&rft.inventor=LAPOINTE%2C+JEAN-MARTIN&rft.inventor=MARTIN%2C+KIRSTY-JANE&rft.inventor=VAUGHAN%2C+TRISTAN&rft.inventor=AUSTIN%2C+MARK&rft.inventor=BARNARD%2C+MICHELLE&rft.inventor=SLATER%2C+LOUISE&rft.inventor=ANDERSON%2C+GEORGINA&rft.inventor=DIAMANDAKIS%2C+AGATA&rft.inventor=HAWTHORNE%2C+WILLIAM&rft.date=2023-06-15&rft.externalDBID=A1&rft.externalDocID=CA3240598A1